Daniel Kisner

Track

Insider profile

Currently holds a position at Zynerba Pharmaceuticals Inc

Performance

Overall performance
2.3
Performance over holding periods
2.3
30 days 90 days 120 days
Average return 16% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Director Zynerba Pharmaceuticals Inc Aug. 6, 2015 -
Daniel Kisner's trades of Zynerba Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
143.70
Quantity 71,606 -26.1%
Value US$4,668,857
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-06-15 2023-06-14
S Sale
35,634 -17.7%
306.98
US$3,399,405 		35,634 -17.7% 306.98 US$3,399,405
2022-06-16 2022-06-14
S Sale
64,349 +29.1%
193.49
US$4,282,997 		64,349 +29.1% 193.49 US$4,282,997
2020-07-23 2020-07-21
B Purchase
71,606 -26.1%
143.70
US$4,668,857 		71,606 -26.1% 143.70 US$4,668,857